Skip to main content
Back to companies
New YorkFounded 201835+ employeesPrivate
$33.5M raisedGrant· last: grant (Jan 2024)· 8 rounds

C16 Biosciences is decarbonizing consumer products supply chains by producing next-generation ingredients. The company's biomanufacturing platform produces better performing, more sustainable alternatives to oils and fats, and their first product is an alternative to palm oil. The company owns and operates Palmless™ alternative fats and oils.

Founders

Skip jobs list

Open Positions at C16 Biosciences (0 Jobs)

No open positions at the moment.
Try adjusting your filters or browse all jobs
Browse All Jobs